Global Artificial Intelligence (AI) in Precision Medicine Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Artificial Intelligence (AI) in Precision Medicine Market 2023 by Company, Regions, Type and Application, Forecast to 2029

According to our (Global Info Research) latest study, the global Artificial Intelligence (AI) in Precision Medicine market size was valued at USD 1847 million in 2022 and is forecast to a readjusted size of USD 5577 million by 2029 with a CAGR of 17.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Targeting the appropriate medications to the appropriate patients at the appropriate times is the aim of precision medicine. Precision medicine has already produced significant new findings and FDA-approved therapies that are tailored to a person’s unique traits, such as their genetic makeup or the genetic profile of their tumor. Molecular testing is frequently administered to patients with different types of cancer as part of patient care, allowing medical professionals to choose therapies that raise survival rates and lower the risk of side effects.

This report is a detailed and comprehensive analysis for global Artificial Intelligence (AI) in Precision Medicine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Artificial Intelligence (AI) in Precision Medicine market size and forecasts, in consumption value ($ Million), 2018-2029

Global Artificial Intelligence (AI) in Precision Medicine market size and forecasts by region and country, in consumption value ($ Million), 2018-2029

Global Artificial Intelligence (AI) in Precision Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029

Global Artificial Intelligence (AI) in Precision Medicine market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Artificial Intelligence (AI) in Precision Medicine

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Artificial Intelligence (AI) in Precision Medicine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Atomwise Inc, Alphabet Inc., AstraZeneca, BioXcel Therapeutics Inc. and Berg LLC, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Artificial Intelligence (AI) in Precision Medicine market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Hardware
Software and Service

Market segment by Application
Oncology
Neurology
Cardiology
Respiratory
Others

Market segment by players, this report covers
Atomwise Inc
Alphabet Inc.
AstraZeneca
BioXcel Therapeutics Inc.
Berg LLC
Enlitic Inc.
GE Healthcare
Insilico Medicine
Intel Corporation
IQVIA
IBM Corporation
Modernizing Medicine Inc.
NVIDIA Corporation
Microsoft Corporation
Novo Nordisk A/S
Sanofi
Sensely Inc.
Tempus
Zephyr AI

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Artificial Intelligence (AI) in Precision Medicine product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Artificial Intelligence (AI) in Precision Medicine, with revenue, gross margin and global market share of Artificial Intelligence (AI) in Precision Medicine from 2018 to 2023.

Chapter 3, the Artificial Intelligence (AI) in Precision Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Artificial Intelligence (AI) in Precision Medicine market forecast, by regions, type and application, with consumption value, from 2024 to 2029.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War

Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Intelligence (AI) in Precision Medicine.

Chapter 13, to describe Artificial Intelligence (AI) in Precision Medicine research findings and conclusion.